Pharmaceuticals

Prescription Drugs Industry Poised for Rapid Growth, Forecast to Touch $2368.39 Billion by 2030 at 10.5% CAGR

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the prescription drugs market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Prescription Drugs Market expected to reach by 2030?

The prescription drugs market size has seen rapid expansion in recent years. It is anticipated to increase from $1430.3 billion in 2025 to $1586.02 billion in 2026, registering a compound annual growth rate (CAGR) of 10.9%. The historical growth of this market can be attributed to factors like the expansion of pharmaceutical manufacturing capacity, an increasing prevalence of chronic diseases, the development of branded drug portfolios, rising healthcare expenditure, and the broadening of hospital-based drug dispensing.

The prescription drugs market size is anticipated to experience substantial growth over the coming years, expanding to $2368.39 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This expansion during the forecast period can be ascribed to a heightened demand for economical generics, a greater adoption of biosimilars, the proliferation of digital prescription platforms, an increasing focus on tailored drug therapies, and improved regulatory synchronization across different markets. Noteworthy trends predicted for this period involve the wider acceptance of specialty prescription drugs, a rising need for generic drug alternatives, an intensified focus on managing chronic diseases, the growth of biologic and biosimilar treatments, and a more stringent regulatory oversight concerning drug safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20597&type=smp

What Drivers Are Driving Adoption Within The Prescription Drugs Market?

The rise in drug manufacturing is projected to fuel the expansion of the prescription drug market in the future. Drug manufacturing involves the structured process of producing pharmaceutical goods, covering their development, testing, and packaging to ensure their quality, safety, and efficacy. Boosting drug production is vital for addressing the increasing worldwide need for medicines, tackling public health issues, and guaranteeing prompt access to therapies for various medical conditions. Enhanced drug production can improve accessibility, cost-effectiveness, and advancements within the prescription drug market, ultimately benefiting patients and the healthcare system through better access to essential medications and improved health outcomes. For instance, in October 2025, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based organization representing the pharmaceutical sector, the European pharmaceutical industry experienced substantial production, rising from $438 billion (€405,701 million) in 2023 to $475 billion (€440,000 million) in 2024. Consequently, higher drug production will stimulate the growth of the prescription drug market.

How Is The Prescription Drugs Market Organized Into Various Segments?

The prescription drugs market covered in this report is segmented –

1) By Type: Branded, Generics

2) By Route Of Administration: Oral, Topical, Parenteral, Other Routes Of Administration

3) By Therapy Area: Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynecology, Endocrinology, Other Therapy Areas

4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Branded: Innovative Drugs, Patented Drugs, Blockbuster Drugs, Over-the-Counter (OTC) Prescription Drugs, Biosimilars, Specialty Drugs, Orphan Drugs, Combination Drugs

2) By Generics: Small Molecule Generics, Generic Biologics, Over-the-Counter (OTC) Generics, Authorized Generics, Generic Combination Drugs, High-Volume Generics, Generic Versions Of Blockbuster Drugs

Which Competitive Trends Are Impacting The Structure Of The Prescription Drugs Market?

Major companies in the prescription drug market are creating alternatives to Victoza (liraglutide) or similar GLP-1 receptor agonist therapies to provide better options for managing type 2 diabetes. Victoza is a brand-name prescription drug that contains the active ingredient liraglutide, which acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily used to manage type 2 diabetes in adults and children aged 10 years and older. For example, in June 2024, Teva Announces, a company based in Israel, introduced an authorized generic of Victoza (liraglutide injection 1.8 mg). This launch offers a more affordable alternative while retaining the same formulation, efficacy, and quality as the original branded product, thereby aiming to improve access to essential diabetes treatments for patients, providing cost-effective choices for managing type 2 diabetes and reducing associated cardiovascular risks.

Who Are The Primary Competitors In The Global Prescription Drugs Market?

Major companies operating in the prescription drugs market are Pfizer Inc., Johnson & Johnson Private Limited, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Allergan plc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/prescription-drugs-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Prescription Drugs Market?

North America was the largest region in the prescription drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Prescription Drugs Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20597&type=smp

Browse Through More Reports Similar to the Global Prescription Drugs Market 2026, By The Business Research Company

Pancreatic Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report

Breast Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report

Lung Cancer Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795